Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


Summary Technicals Candle Volatility Recent Patterns Peers Interactive Charts EMA Historical Charts

Fundamental Analysis of Venus Remedies (VENUSREM)

Beta - Please note that this feature is in early testing phase. We believe that data is validated but it may contain some discrepancies
Fundamental Screeners - As always we try to provide you with best screener quality that matters to you. In continuation to that approach you can submit your requirements at Request for a Fundamental Screener

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

CAGR Growth - Venus Remedies Ltd

CAGR Growth Period Book value Per Share % Operating cash Flow % Earning Per Share % Dividend % EBITDA % Net Income % Revenue % Revenue Per share % Operating Profit % Operating Profit Per Share% EBITDA Per share % Year Range
1 Year -4.638 144.71 266.67 0.000 -5.472 295.83 -6.765 -13.565 -5.681 -12.560 -12.367 16-17
3 Year -3.205 24.96 -58.346 0.000 -17.210 -57.286 -10.634 -12.857 -17.416 -19.470 -19.269 14-17
5 Year 3.08 21.93 -40.436 0.000 -6.564 -37.556 -1.513 -6.061 -6.694 -11.003 -10.879 12-17
7 Year 8.27 16.48 -30.356 0.000 0.232 -26.515 2.68 -2.686 0.105 -5.130 -5.009 10-17
10 Year 18.20 14.31 -19.618 0.000 7.06 -16.474 10.27 6.12 7.68 3.63 3.03 07-17

Balance Sheet of Venus Remedies Ltd

Year Book Value Per Share Capital Work In Progress Net Block Reserves EQ Capital Shareholdings Working Capital Shareholder's Funds Total Debt Current Liablities Total Liablities Cash & Bank Balances Total Assets Capital Employed Current Assets
31_Mar_17 370.47 74.63 443.90 444.82 12.34 218.03 457.16 308.14 67.56 375.70 3.15 832.86 765.30 285.59
31_Mar_16 388.49 80.37 433.52 432.99 11.44 228.73 444.43 326.93 62.70 389.63 3.04 834.06 771.36 291.43
Balance sheet for last 13 Years with 14 Indicators



Cash Flow of Venus Remedies Ltd

Year Cash EPS Cash From Financial Activity Cash From Investing Activity Cash From Operating Activity Net cash Flow
31_Mar_17 83.11 -56.580 -45.870 102.56 0.110
31_Mar_16 36.63 -45.590 3.20 41.91 -0.480
Cash Flow for last 13 Years

Income Statement of Venus Remedies Ltd

Year Corporate Tax Rate Depreciation Expense Total Dividend EBITDA EPS (Earning Per Share) Income Tax Interest Net Income Outstanding Shares Operating Profit Other Income Profit Before Tax Revenue Operating Expense Dividend Total Income Profit Before Depreciation And Tax
31_Mar_17 -3.524 41.22 0.000 75.83 3.85 -3.700 33.56 4.75 1.23 75.04 0.790 1.05 375.45 300.41 0.000 376.24 42.27
31_Mar_16 0.601 40.47 0.000 80.22 1.05 1.81 36.74 1.20 1.14 79.56 0.670 3.01 402.69 323.13 0.000 403.36 43.48
Income Statement for last 13 Years with 17 Parameters

Quarterly Income Statement Venus Remedies Ltd

Quarter Corporate Tax Rate Depreciation Expense EBITDA EPS Income Tax Expense Interest Net Income OutStanding Shares Operating Profit Other Income Revenue Total Annual Dividend Total Income Operating Expense Profit Before Depreciation and Tax Face Value
31_Dec_17 0.000 8.88 17.85 0.440 0.000 8.43 0.540 1.23 17.71 0.140 93.13 0.000 93.27 75.42 9.42 10.00
30_Sep_17 0.000 7.52 17.18 0.770 0.000 8.71 0.950 1.23 17.06 0.120 90.51 0.000 90.63 73.45 8.47 10.00
Quarterly Income Statement for last 22 Quarters with 16 Parameters



Risk , price and valuations of Venus Remedies Ltd

Year Market cap Dividend Yield Earning Yield Account Cost of Debit Cost of Equity (CAPM Model) Credit/Default Spread Levered Beta PEG (Price by earning To Growth) PBV (Price To Book Value) PE (Price To earning) PS (Price to Sales - Revenue) Weight to debt (WACC) Weight of equity (WACC) WACC (Weighted cost of Capital) PCFO (Price to cash Flow from Operations) Enterprise value
31_Mar_17 120.65 0.000 0.040 0.109 0.155 0.080 0.700 0.100 0.260 25.40 0.320 0.719 0.281 0.122 1.18 425.64
31_Mar_16 102.39 0.000 0.010 0.112 0.167 0.080 0.890 -1.150 0.230 85.33 0.250 0.762 0.238 0.127 2.44 426.28
Risk Price & Valuation for last 13 Years with 16 Parameters

Profitability And Management Efficiency of Venus Remedies Ltd

Year CROCI (Cash Returns on Capital Invested) Days in Working Capital EBITDA Margin Net Margin Operating cash Flow to Revenue Operating Margin ROCE (Return on Capital Employed) ROE (Return on Equity) Current ratio ROA (return on Assets) ROIC (Return on Invested capital) Asset Turnover CFO To Sales CFO To Turnover(TO) WC to TO Fixed Asset (FA) to TO CFROA (CF to ROA)
31_Mar_17 0.099 209.06 0.202 0.013 0.273 0.200 0.045 0.010 4.23 0.006 0.010 0.451 0.270 119.19 1.72 0.846 0.123
31_Mar_16 0.104 204.48 0.199 0.003 0.104 0.198 0.052 0.003 4.65 0.001 0.000 0.906 0.100 132.46 1.76 0.929 0.050
Profitability & Management Efficiency for last 13 Years with 17 Parameters

Quarterly Profitability /Ratios of Venus Remedies Ltd

Quarter EBITDA Margin IBT Margin Net Margin Operating Margin) Market Capitalization Dividend Yield Levered Beta Dividend Payout Retention Ratio
31_Dec_17 0.192 0.006 0.006 0.190 126.79 0.000 0.000 0.000 0.000
30_Sep_17 0.190 0.010 0.010 0.188 120.01 0.000 0.000 0.000 0.000
Profitability & Management Efficiency for last 22 Quarters with 9 Parameters


Solvency & Fundamentals of Venus Remedies Ltd

Year Capitalization Ratio Interest Coverage Long Term Debt to EBITDA Long Term Debt to Equity (Net Worth) Solvency Ratio Dividend Payout Retention Ratio Times Interest Earned Cash Ratio Accruals CFO to Debt Debt To Assets Debt To Capital Assets to Shareholder Equity Dividend Cover
31_Mar_17 0.400 1.03 4.06 0.670 0.150 0.000 1.00 0.970 0.050 -97.810 0.330 0.370 0.400 1.82 0.000
31_Mar_16 0.420 1.08 4.08 0.740 0.130 0.000 1.00 0.930 0.050 -40.710 0.130 0.390 0.420 1.88 0.000
Solvency & Fundamentals for last 13 Years with 15 Parameters

Financial Data From D'Market

Be the first to comment


(All analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.